newsfilter
← Latest News
Business Wire·

Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline

Perfuse Therapeutics' investigational lead program shows potential to become one of the first disease-modifying treatments for both Glaucoma and Diabetic Retinopathy (DR) High unmet medical need of patients with